Additional file 4: Figure S1. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Authors :: Pinto-Mariz, Fernanda
Carvalho, Luciana Rodrigues
Araujo, Alexandra Prufer De Queiroz Campos
Mello, Wallace De
MĂĄrcia GonĂ§Alves Ribeiro
Cunha, Maria
Cabello, Pedro
Riederer, Ingo
Negroni, Elisa
Desguerre, Isabelle
Veras, Mariana
Yada, Erica
Allenbach, Yves
Benveniste, Olivier
Voit, Thomas
Mouly, Vincent
Silva-Barbosa, Suse
Butler-Browne, Gillian
Savino, Wilson
Publisher :: Figshare
Abstract: Gating procedures for cytofluorometric labeling of CD49d in freshly isolated leukocytes from the blood of normal subjects and Duchenne muscular dystrophy patients. (DOC 108 kb)

Tools